NeuTec Pharma PLC
25 February 2005
NEUTEC PHARMA PLC ('The Company')
25 February 2005: The Company was notified today that two Non-Executive
Directors, Dr Robert Nolan and Mr Russell Race, have respectively purchased 173
and 209 ordinary shares, of 25p each in the Company ('Shares').
This share purchase has been undertaken in accordance with the binding monthly
commitment (as set out in their terms of appointment) whereby Dr Robert Nolan
and Mr Russell Race have their monthly Board fee (net of tax) invested in the
equity of NeuTec Pharma Plc by way of purchases in the market conducted through
the Company's stockbroker.
Following these purchases, Dr Robert Nolan's total holding in NeuTec Pharma
amounts to 5,119 Ordinary shares, representing 0.017% of the Company's
outstanding shares, and Mr Russell Race's total holding in NeuTec Pharma amounts
to 9,975 representing 0.034% of the Company's outstanding shares. This is based
on the issued share capital of 29, 015, 998 shares.
For further details please contact:
NeuTec Pharma plc www.neutecpharma.com
Andrew King, Finance Director 0161 276 8827
Ben Atwell 020 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange D